Publication Date:
2015-08-04
Description:
by Davide Bolignano, Graziella D’Arrigo, Anna Pisano, Giuseppe Coppolino Background Pentoxifylline (PTX) is a promising therapeutic approach for reducing inflammation and improving anemia associated to various systemic disorders. However, whether this agent may be helpful for anemia management also in CKD patients is still object of debate. Study Design Systematic review and meta-analysis. Population Adults with CKD (any KDOQI stage, including ESKD patients on regular dialysis) and anemia (Hb
Electronic ISSN:
1932-6203
Topics:
Medicine
,
Natural Sciences in General